Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Dyne Therapeutics, Inc. (DYN) had Return on Investments of -50.40% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-317.42M |
|
-- |
|
-- |
|
$343.89M |
|
$-343.89M |
|
$26.47M |
|
$-317.42M |
|
$-317.42M |
|
$-317.42M |
|
$-317.42M |
|
$-317.42M |
|
$-317.42M |
|
$-343.89M |
|
$-345.82M |
|
94.14M |
|
94.14M |
|
$-3.37 |
|
$-3.37 |
|
| Balance Sheet Financials | |
$659.28M |
|
$5.40M |
|
$31.95M |
|
$691.23M |
|
$42.26M |
|
-- |
|
$19.14M |
|
$61.40M |
|
$629.84M |
|
$629.84M |
|
$629.84M |
|
102.32M |
|
| Cash Flow Statement Financials | |
$-292.37M |
|
$-204.08M |
|
$809.89M |
|
$123.94M |
|
$437.39M |
|
$313.45M |
|
$45.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-294.75M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-50.40% |
|
-50.40% |
|
-45.92% |
|
|
Return on Investments |
-50.40% |
$6.16 |
|
$-3.13 |
|
$-3.11 |
|